Medtechs need to up their cybersecurity threat modeling game, FDA says

The agency “will be looking for much more detailed and comprehensive” cyber threat models as part of premarket review, said Suzanne Schwartz, director of CDRH’s Office of Strategic Partnerships and Technology Innovation.